Skip to main content
. 2021 Oct 30;126(1):79–90. doi: 10.1038/s41416-021-01602-8

Fig. 5. Decision curve analysis demonstrated the improved clinical net benefit of multivariate models integrating miR-181a with the established clinical markers.

Fig. 5

a, b Decision curves of the multivariate prediction models for the overall survival (OS; a) and progression-free survival (PFS; b) of MM patients. Net benefit is plotted against various ranges of threshold probabilities.